Reporting on transactions in Danish Aerospace Company A/S’ shares by persons closely associated with persons discharging managerial responsibilities
COMPANY ANNOUNCEMENT
Odense, April 15, 2026
Company Announcement no. 84 – April 15, 2026
Reporting on transactions in Danish Aerospace Company A/S’ shares by persons closely associated with persons discharging managerial responsibilities
Danish Aerospace Company A/S
CVR no.: 12 42 42 48
Danish Aerospace Company A/S (“DAC” or the “Company”) has received notification pursuant to article 19 of the Market Abuse Regulation (EU) no. 596/2014 of the below transactions related to shares in DAC made by persons discharging managerial responsibilities in DAC and persons closely to them.
In connection with the Company’s rights issue, which was announced by the Company in company announcement no. 80 published on March 19, 2026 (the “Offering”), the attached transactions have been made by persons discharging managerial responsibilities in DAC and persons closely associated with them in DAC’s shares and other financial instruments linked thereto. Reference is made to company announcement no. 81 published by the Company on April 14, 2026 regarding the results of the Offering.
Transactions made in connection with the Offering
DAC has received notifications on transactions notifiable under the Market Abuse Regulation article 19 from:
- Niels Heering, Chair of the Board of Directors
- Silver Bear Holdings ApS (closely associated person to Søren Bjørn Hansen, Deputy Chair of the Board of Directors)
- M. Goldschmidt Capital A/S (closely associated person to Søren Bjørn Hansen, Deputy Chair of the Board of Directors)
Please contact the following for further information:
Danish Aerospace Company A/S
Thomas A.E. Andersen, CEO
Tel.: +45 40 29 41 62
Email: ta@danishaerospace.com
Certified Adviser
HC Andersen Capital
Tel.: +45 30 93 18 87
Email: ca@hcandersencapital.dk
Bredgade 23B, 2nd Floor
1260 Copenhagen K
Information about the Company
The Company develops and manufactures exercise equipment, biomedical health monitoring equipment, and water filtration equipment for manned spaceflight, which can also be used by the military and in other extreme environments. For example, the Company has developed six generations of pulmonary physiological equipment for manned spaceflight, as well as several generations of ergometers and a new combined training device to help astronauts maintain their physical fitness.
The equipment is also particularly relevant for situations on the ground where training and health monitoring are required, and in certain cases essential for survival under extreme and particularly demanding conditions. The Company is able to deliver highly reliable equipment thanks to its current staff of over 22 highly skilled employees specialising in fields such as electronics, mechanics, and software programming, and has specialised in customer-specific design, development, and manufacturing of advanced equipment.
With more than 35 years of experience, exclusive rights to certain key technologies for use in the space industry, as well as non-exclusive rights for use in the defence sector, and four patents on the technology in one of the Company’s new E4D products, as well as recognised reference customers and a solid track record from many years of collaboration with the international space agencies NASA and ESA, it is the Management’s assessment that the Company holds a unique position in the growing market for advanced biomedical equipment, both in the aerospace industry and in other extreme environments. The Company intends to leverage this positioning to expand its customer portfolio to include commercial customers within the aerospace industry, as well as the defence sector and other industries operating in extreme environments.